CDKN2A and colorectal carcinoma: The activated K-RAS protein was demonstrated to be able to accelerate the hypermethylation of transcription factors of tumor suppressor genes (e.g. INK4-ARF) in several colorectal carcinoma cell lines [33], and thereby to epigenetically silence the expression of these tumor suppressor genes.